| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.24761 |
| P698 | PubMed publication ID | 19714649 |
| P50 | author | Matthew R McCann | Q52924116 |
| P2093 | author name string | Andrew Leask | |
| Christopher P Denton | |||
| Mohit Kapoor | |||
| David J Abraham | |||
| Shangxi Liu | |||
| Kun Huh | |||
| P433 | issue | 9 | |
| P304 | page(s) | 2822-2829 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis | |
| P478 | volume | 60 |
| Q35623780 | A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis |
| Q33637862 | A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses |
| Q47617068 | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis |
| Q89572849 | Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis |
| Q33860888 | Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. |
| Q28390528 | Animal models of systemic sclerosis: their utility and limitations |
| Q38873681 | Autophagy: controlling cell fate in rheumatic diseases |
| Q42252132 | Cellular and molecular mechanisms of intestinal fibrosis |
| Q37624991 | Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition |
| Q37721063 | Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy |
| Q36012572 | Fibrosis in systemic sclerosis: common and unique pathobiology |
| Q38206104 | Fibrosis--a lethal component of systemic sclerosis |
| Q41816319 | Getting out of a sticky situation: targeting the myofibroblast in scleroderma |
| Q47109594 | Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis |
| Q36245922 | Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? |
| Q41879637 | Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis |
| Q39629362 | Loss of PPARγ expression by fibroblasts enhances dermal wound closure |
| Q43169841 | PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage |
| Q33745028 | PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis |
| Q35954579 | Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis |
| Q37959975 | Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise |
| Q37864123 | Possible strategies for anti-fibrotic drug intervention in scleroderma |
| Q28088499 | Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance |
| Q36093802 | Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis |
| Q40745671 | Role of prostaglandins in fibroblast activation and fibrosis |
| Q47610065 | Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta. |
| Q52605977 | Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression. |
| Q91897242 | TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts |
| Q38097276 | Targeted therapies for systemic sclerosis |
| Q26865930 | The Contribution of Peroxisome Proliferator-Activated Receptor Gamma to Cutaneous Wound Healing |
| Q35503543 | The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects |
| Q38524619 | The Role of PPAR Gamma in Systemic Sclerosis |
| Q97076303 | The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review |
| Q37638268 | Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities |
| Q36537631 | mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis |
Search more.